Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.08 Analyst target: $17.16 Upside: 1488.89%
Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company is headquartered in Carlton, Australia.
See the full interactive analysis & chart →Informational only — not investment advice.